Top Markets
Coin of the day
Orexo AB Orexo AB

Orexo AB

ORX
Rankning i aktier #24889
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Aktiekurs
$1.58
Marknadsvärde
$55.48M
Förändring (1 dag)
0.86%
Förändring (1 år)
-28.33%
Land
SE
Handel Orexo AB (ORX)

Kategori

Aktiekurshistorik för Orexo AB (ORX)
Högsta slutkurs: $1.66 den 2026-08-01

Lägsta slutkurs: $10.87 den 2005-11-01
Aktiekurshistorik för Orexo AB från 2005 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -0.36%
2025 71.17%
2024 1.53%
2023 -16.60%
2022 -53.35%
2021 -27.52%
2020 -16.22%
2019 -4.07%
2018 41.00%
2017 22.89%
2016 -47.52%
2015 -55.53%
2014 -33.94%
2013 226.23%
2012 110.17%
2011 -35.82%
2010 15.15%
2009 9.60%
2008 -38.49%
2007 -59.09%
2006 46.28%
2005 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$60.43 66.43%
US
$51.27 72.45%
SE
$192.16 42.27%
FR
$119.82 68.80%
US
$0.72 -27.55%
HK